{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:11:35Z","timestamp":1773299495030,"version":"3.50.1"},"reference-count":32,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"unspecified","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["MCT-82072"],"award-info":[{"award-number":["MCT-82072"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,9,20]]},"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To study participant\u2019s acceptability of and attitudes towards human papillomavirus (HPV) testing compared with cytology for cervical cancer screening and what impact having an HPV positive result may have in future acceptability of screening.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Cross-sectional online survey of clinical trial participants.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>Primary care, population-based Cervix Screening Program, British Columbia, Canada.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Participants<\/jats:title>\n                  <jats:p>A total of 5532 participants from the HPV FOCAL trial, in which women received HPV and cytology testing at study exit, were included in the analysis. Median age was 54 years. The median time of survey completion was 3 years after trial exit.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Outcome measures<\/jats:title>\n                  <jats:p>Acceptability of HPV testing for primary cervical cancer screening (primary); attitudes and patient perceptions towards HPV testing and receipt of HPV positive screen results (secondary).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Most respondents (63%) were accepting of HPV testing, with the majority (69%) accepting screening to begin at age 30 years with HPV testing. Only half of participants (54%) were accepting of an extended screening interval of 4\u20135 years. In multivariable logistic regression, women who received an HPV positive screen test result during the trial (OR=1.41 95%\u2009CI 1.11 to 1.80) or were older (OR=1.01, 95%\u2009CI 1.00 to 1.02) were more likely to report HPV testing as acceptable.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In this evaluation of acceptability and attitudes regarding HPV testing for cervix screening, most are accepting of HPV testing for screening; however, findings indicate heterogeneity in concerns and experiences surrounding HPV testing and receipt of HPV positive results. These findings provide insights for the development of education, information and communication strategies during implementation of HPV-based cervical cancer screening.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration numbers<\/jats:title>\n                  <jats:p>\n                     <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"isrctn\" xlink:href=\"ISRCTN79347302\">ISRCTN79347302<\/jats:ext-link> and <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT00461760\">NCT00461760<\/jats:ext-link>.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-052084","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T23:31:33Z","timestamp":1633822293000},"page":"e052084","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Women\u2019s acceptability of and experience with primary human papillomavirus testing for cervix screening: HPV FOCAL trial cross-sectional online survey results"],"prefix":"10.1136","volume":"11","clinical-trial-number":[{"clinical-trial-number":"nct00461760","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"isrctn79347302","registry":"10.18810\/isrctn"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9463-1713","authenticated-orcid":false,"given":"Laurie W","family":"Smith","sequence":"first","affiliation":[{"name":"Department of Cancer Control Research, BC Cancer Agency, Vancouver, British Columbia, Canada"},{"name":"Women's Health Research Institute, BC Women's Hospital and Health Centre, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C Sarai","family":"Racey","sequence":"additional","affiliation":[{"name":"Women's Health Research Institute, BC Women's Hospital and Health Centre, Vancouver, British Columbia, Canada"},{"name":"Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lovedeep","family":"Gondara","sequence":"additional","affiliation":[{"name":"Department of Data and Analytics, BC Cancer Agency, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mel","family":"Krajden","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Public Health Laboratory, BC Centre for Disease Control, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marette","family":"Lee","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Cervix Screening Program, BC Cancer Agency, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth Elwood","family":"Martin","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin","family":"Stuart","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Peacock","sequence":"additional","affiliation":[{"name":"Department of Cancer Control Research, BC Cancer Agency, Vancouver, British Columbia, Canada"},{"name":"Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J","family":"Coldman","sequence":"additional","affiliation":[{"name":"Department of Cancer Control Research, BC Cancer Agency, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4409-8084","authenticated-orcid":false,"given":"Eduardo L","family":"Franco","sequence":"additional","affiliation":[{"name":"Department of Oncology, McGill University, Montreal, Qu\u00e9bec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"van Niekerk","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Cervix Screening Program, BC Cancer Agency, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5783-4493","authenticated-orcid":false,"given":"Gina S","family":"Ogilvie","sequence":"additional","affiliation":[{"name":"Women's Health Research Institute, BC Women's Hospital and Health Centre, Vancouver, British Columbia, Canada"},{"name":"Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,10,7]]},"reference":[{"key":"2025101812405306000_11.10.e052084.1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F"},{"key":"2025101812405306000_11.10.e052084.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2008.07.045"},{"key":"2025101812405306000_11.10.e052084.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.7464"},{"key":"2025101812405306000_11.10.e052084.4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.10400"},{"key":"2025101812405306000_11.10.e052084.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62218-7"},{"key":"2025101812405306000_11.10.e052084.6","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30 Suppl 5","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"key":"2025101812405306000_11.10.e052084.7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4924"},{"key":"2025101812405306000_11.10.e052084.8","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32540"},{"key":"2025101812405306000_11.10.e052084.9","doi-asserted-by":"publisher","DOI":"10.1002\/pon.5198"},{"key":"2025101812405306000_11.10.e052084.10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-019171"},{"key":"2025101812405306000_11.10.e052084.11","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-111"},{"key":"2025101812405306000_11.10.e052084.12","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.489"},{"key":"2025101812405306000_11.10.e052084.13","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/bjc.2016.368","article-title":"Disease detection and resource use in the safety and control arms of the HPV focal cervical cancer screening trial","volume":"115","author":"Coldman","year":"2016","journal-title":"Br J Cancer"},{"key":"2025101812405306000_11.10.e052084.14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/ijc.30454","article-title":"Hpv for cervical cancer screening (HPV focal): complete round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer","volume":"140","author":"Ogilvie","year":"2017","journal-title":"Int J Cancer"},{"key":"2025101812405306000_11.10.e052084.15","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28324"},{"key":"2025101812405306000_11.10.e052084.16","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jogc.2016.04.009","article-title":"Recommendations for implementing human Papillomavirus-Based cervical cancer screening: lessons learned from the HPV focal trial","volume":"38","author":"Smith","year":"2016","journal-title":"J Obstet Gynaecol Can"},{"key":"2025101812405306000_11.10.e052084.17","unstructured":"The American Association for Public Opinion Research . Standard definitions: final dispositions of case codes and outcome rates for surveys. 9th Edition, 2016. https:\/\/www.aapor.org\/AAPOR_Main\/media\/publications\/Standard-Definitions20169theditionfinal.pdf"},{"key":"2025101812405306000_11.10.e052084.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2018.08.034"},{"key":"2025101812405306000_11.10.e052084.19","doi-asserted-by":"crossref","unstructured":"Ogilvie GS , Smith LW , van Niekerk D , et al . Correlates of women\u2019s intentions to be screened for human papillomavirus for cervical cancer screening with an extended interval. BMC Public Health 2016;16.doi:10.1186\/s12889-016-2865-8","DOI":"10.1186\/s12889-016-2865-8"},{"key":"2025101812405306000_11.10.e052084.20","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-039041"},{"key":"2025101812405306000_11.10.e052084.21","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000638"},{"key":"2025101812405306000_11.10.e052084.22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ypmed.2016.11.028","article-title":"Understanding women's hesitancy to undergo less frequent cervical cancer screening","volume":"95","author":"Gerend","year":"2017","journal-title":"Prev Med"},{"key":"2025101812405306000_11.10.e052084.23","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.134"},{"key":"2025101812405306000_11.10.e052084.24","first-page":"1","article-title":"Emotional response to testing positive for human papillomavirus at cervical cancer screening: a mixed method systematic review with meta-analysis","author":"McBride","year":"2020","journal-title":"Health Psychol Rev"},{"key":"2025101812405306000_11.10.e052084.25","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2019-054290"},{"key":"2025101812405306000_11.10.e052084.26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2004.00279.x"},{"key":"2025101812405306000_11.10.e052084.27","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2006.023333"},{"key":"2025101812405306000_11.10.e052084.28","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/08870446.2013.834057","article-title":"The blame game: cervical cancer, knowledge of its link to human papillomavirus and stigma","volume":"29","author":"Shepherd","year":"2014","journal-title":"Psychol Health"},{"key":"2025101812405306000_11.10.e052084.29","doi-asserted-by":"publisher","DOI":"10.1177\/1049732311424404"},{"key":"2025101812405306000_11.10.e052084.30","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/pon.4694","article-title":"Hpv primary cervical screening in England: women's awareness and attitudes","volume":"27","author":"Patel","year":"2018","journal-title":"Psychooncology"},{"key":"2025101812405306000_11.10.e052084.31","doi-asserted-by":"crossref","unstructured":"Bennett KF , Waller J , Ryan M . Concerns about disclosing a high-risk cervical human papillomavirus (HPV) infection to a sexual partner: a systematic review and thematic synthesis. BMJ Sexual and Reproductive Health 2019.","DOI":"10.1136\/bmjsrh-2019-200503"},{"key":"2025101812405306000_11.10.e052084.32","doi-asserted-by":"publisher","DOI":"10.1177\/0009922814551135"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-052084","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T19:41:08Z","timestamp":1760816468000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-052084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":32,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10,7]]},"published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10.1136\/bmjopen-2021-052084"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-052084","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}